Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04619680 |
|---|---|
| Brief Title: | The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 (ENDCOV-I) |
| First Submitted : | November 5, 2020 |
| First Submitted that Met QC Criteria : | November 5, 2020 |
| First Posted : | November 6, 2020 |
| Last Update Submitted that Met QC Criteria : | October 9, 2022 |
| Last Update Posted : | October 12, 2022 |